The short- and long-term risk of stroke after herpes zoster - a nationwide population-based cohort study.

<h4>Background and objective</h4>Varicella zoster virus (VZV) is known to cause VZV vasculopathy, which may be associated with stroke. A recent study found an increased risk of stroke within one year of herpes zoster. We aimed to investigate the short and long-term effects of herpes zost...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Nandini Sreenivasan, Saima Basit, Jan Wohlfahrt, Björn Pasternak, Tina N Munch, Lars P Nielsen, Mads Melbye
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2013
Materias:
R
Q
Acceso en línea:https://doaj.org/article/28d1d2e003f94ed493253b7f7c0e5e3f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:28d1d2e003f94ed493253b7f7c0e5e3f
record_format dspace
spelling oai:doaj.org-article:28d1d2e003f94ed493253b7f7c0e5e3f2021-11-18T07:37:22ZThe short- and long-term risk of stroke after herpes zoster - a nationwide population-based cohort study.1932-620310.1371/journal.pone.0069156https://doaj.org/article/28d1d2e003f94ed493253b7f7c0e5e3f2013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23874897/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background and objective</h4>Varicella zoster virus (VZV) is known to cause VZV vasculopathy, which may be associated with stroke. A recent study found an increased risk of stroke within one year of herpes zoster. We aimed to investigate the short and long-term effects of herpes zoster on the risk of stroke.<h4>Methods</h4>Using Danish national registers, we constructed a cohort consisting of all Danish adults ≥18 years old between 1995 and 2008 (n = 4.6 million; person-years of follow-up = 52.9 million). Individual-level information on prescriptions for herpes zoster antiviral treatment and diagnoses of stroke was obtained from national registers. We compared the risk of stroke in persons who had received the specific dosage of acyclovir for herpes zoster with persons who had never received antiviral treatment by Poisson regression.<h4>Results</h4>During follow-up, 2.5% received treatment for herpes zoster and 5.0% were diagnosed with stroke. Individuals who had received medication had a 127% (95% CI 83-182%) increased risk the first two weeks, 17% (CI 9-24%) between two weeks and one year, and 5% (2-9%) after the first year. The increased risk was greatest in the youngest age group (<40). To control for healthcare-seeking behaviour, we conducted parallel analyses investigating the risk of selected fractures after herpes zoster and found no similar increased risks.<h4>Conclusions</h4>This large nationwide cohort study found an increased risk of stroke after treatment for herpes zoster. Although the short-term risk was particularly high, we cannot rule out the possibility of a small but important long-term risk.Nandini SreenivasanSaima BasitJan WohlfahrtBjörn PasternakTina N MunchLars P NielsenMads MelbyePublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 7, p e69156 (2013)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Nandini Sreenivasan
Saima Basit
Jan Wohlfahrt
Björn Pasternak
Tina N Munch
Lars P Nielsen
Mads Melbye
The short- and long-term risk of stroke after herpes zoster - a nationwide population-based cohort study.
description <h4>Background and objective</h4>Varicella zoster virus (VZV) is known to cause VZV vasculopathy, which may be associated with stroke. A recent study found an increased risk of stroke within one year of herpes zoster. We aimed to investigate the short and long-term effects of herpes zoster on the risk of stroke.<h4>Methods</h4>Using Danish national registers, we constructed a cohort consisting of all Danish adults ≥18 years old between 1995 and 2008 (n = 4.6 million; person-years of follow-up = 52.9 million). Individual-level information on prescriptions for herpes zoster antiviral treatment and diagnoses of stroke was obtained from national registers. We compared the risk of stroke in persons who had received the specific dosage of acyclovir for herpes zoster with persons who had never received antiviral treatment by Poisson regression.<h4>Results</h4>During follow-up, 2.5% received treatment for herpes zoster and 5.0% were diagnosed with stroke. Individuals who had received medication had a 127% (95% CI 83-182%) increased risk the first two weeks, 17% (CI 9-24%) between two weeks and one year, and 5% (2-9%) after the first year. The increased risk was greatest in the youngest age group (<40). To control for healthcare-seeking behaviour, we conducted parallel analyses investigating the risk of selected fractures after herpes zoster and found no similar increased risks.<h4>Conclusions</h4>This large nationwide cohort study found an increased risk of stroke after treatment for herpes zoster. Although the short-term risk was particularly high, we cannot rule out the possibility of a small but important long-term risk.
format article
author Nandini Sreenivasan
Saima Basit
Jan Wohlfahrt
Björn Pasternak
Tina N Munch
Lars P Nielsen
Mads Melbye
author_facet Nandini Sreenivasan
Saima Basit
Jan Wohlfahrt
Björn Pasternak
Tina N Munch
Lars P Nielsen
Mads Melbye
author_sort Nandini Sreenivasan
title The short- and long-term risk of stroke after herpes zoster - a nationwide population-based cohort study.
title_short The short- and long-term risk of stroke after herpes zoster - a nationwide population-based cohort study.
title_full The short- and long-term risk of stroke after herpes zoster - a nationwide population-based cohort study.
title_fullStr The short- and long-term risk of stroke after herpes zoster - a nationwide population-based cohort study.
title_full_unstemmed The short- and long-term risk of stroke after herpes zoster - a nationwide population-based cohort study.
title_sort short- and long-term risk of stroke after herpes zoster - a nationwide population-based cohort study.
publisher Public Library of Science (PLoS)
publishDate 2013
url https://doaj.org/article/28d1d2e003f94ed493253b7f7c0e5e3f
work_keys_str_mv AT nandinisreenivasan theshortandlongtermriskofstrokeafterherpeszosteranationwidepopulationbasedcohortstudy
AT saimabasit theshortandlongtermriskofstrokeafterherpeszosteranationwidepopulationbasedcohortstudy
AT janwohlfahrt theshortandlongtermriskofstrokeafterherpeszosteranationwidepopulationbasedcohortstudy
AT bjornpasternak theshortandlongtermriskofstrokeafterherpeszosteranationwidepopulationbasedcohortstudy
AT tinanmunch theshortandlongtermriskofstrokeafterherpeszosteranationwidepopulationbasedcohortstudy
AT larspnielsen theshortandlongtermriskofstrokeafterherpeszosteranationwidepopulationbasedcohortstudy
AT madsmelbye theshortandlongtermriskofstrokeafterherpeszosteranationwidepopulationbasedcohortstudy
AT nandinisreenivasan shortandlongtermriskofstrokeafterherpeszosteranationwidepopulationbasedcohortstudy
AT saimabasit shortandlongtermriskofstrokeafterherpeszosteranationwidepopulationbasedcohortstudy
AT janwohlfahrt shortandlongtermriskofstrokeafterherpeszosteranationwidepopulationbasedcohortstudy
AT bjornpasternak shortandlongtermriskofstrokeafterherpeszosteranationwidepopulationbasedcohortstudy
AT tinanmunch shortandlongtermriskofstrokeafterherpeszosteranationwidepopulationbasedcohortstudy
AT larspnielsen shortandlongtermriskofstrokeafterherpeszosteranationwidepopulationbasedcohortstudy
AT madsmelbye shortandlongtermriskofstrokeafterherpeszosteranationwidepopulationbasedcohortstudy
_version_ 1718423149576454144